Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABT

DTM looking to outlaw one-car teams from 2023

The DTM is considering banning one-car teams from taking part in the championship from 2023 due to limited pitlane space at some tracks.

Motorsport

DTM racer Kelvin van der Linde keen to “broaden horizons” beyond GT3

DTM race winner Kelvin van der Linde says he would like to “broaden my horizons” beyond racing GT3 cars after almost a decade in the discipline with Audi.

Motorsport

Mahindra FE principal Gill to depart team ahead of 2022-23 season

Mahindra Formula E principal and CEO Dilbagh Gill will leave the team he has headed up since the championship's very first race in 2014.

Autosport

From analysis to the latest developments in health,
read the most diverse news in one place.

Mahindra FE boss Gill to depart team ahead of 2022-23 season

Mahindra Formula E principal and CEO Dilbagh Gill will leave the team he has headed up since the championship's very first race in 2014.

Motorsport

DTM racer Kelvin van der Linde keen to “broaden horizons” beyond GT3

DTM race-winner Kelvin van der Linde says he would like to “broaden my horizons” beyond racing GT3 cars after almost a decade in the discipline with Audi.

Autosport

Frijns loss of Formula E form in 2021-22 "90% down to brakes"

Robin Frijns put his loss of form during the 2021-22 Formula E season down to a change in brake material and software, which gradually pulled him out of title contention.

Autosport

4 Stocks Investors Could Hold for the Next Decade

Concerns over the Fed’s continued hawkish stance and a potential recession lead to high market volatility. However, no matter what direction the market follows, quality dividend-paying stocks Microsoft (MSFT), Walmart (WMT), Coca-Cola (KO), and Abbott (ABT) could be great investments for the next decade. Read more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

5 Dividend Stocks to Buy and Hold Forever

Persistent economic turbulence and an uncertain outlook have led investors to prioritize steady income generation from their investments. Hence, fundamentally sound dividend yielders with a solid track record and potential for perpetual growth Merck (MRK), Abbott (ABT), Cigna (CI), Energy Transfer (ET), and Kronos (KRO) could be permanent additions to…

StockNews.com

Abt would "trust" Tomczyk to be Berger successor as DTM boss

Abt DTM team principal Thomas Biermaier believes 2011 series champion Martin Tomczyk would be a worthy successor to series boss Gerhard Berger, following an internal reshuffle within organising body ITR.

Autosport

Janet Rolle is Making History With the American Ballet Theater

As the first Black and first female leader of the prestigious dance company, Janet Rolle is hoping to bring art to the masses.

Sports Illustrated

This Is What Whales Are Betting On Abbott Laboratories

Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

How Audi DTM heavyweights Rast and Muller compare

The GT3-based DTM is a different proposition to the Class 1 era that ended in 2020, but Audi’s top protagonists remain the same. Rivals Rene Rast and Nico Muller have now swapped teams, making their Team Rosberg and Abt engineers uniquely qualified to reveal what makes the pair tick

Autosport

5 Stocks With the Most Long-Term Growth Potential

While high inflation and GDP decline for two consecutive quarters are raising recession fears, better-than-expected corporate profits and the possibility of a less aggressive rate hike have been restoring investor confidence. Regardless of the uncertainties surrounding the economy and the market, investing in Abbott Laboratories (ABT), Coca-Cola Consolidated (COKE), DLH…

StockNews.com

The Best Stock to Buy for Long-Term Growth

Healthcare company Abbott Labs (ABT) has demonstrated solid growth over the past years. Moreover, the company announced its plans to restart its baby formula business in Michigan. And considering its fundamental strength, we think the stock might be an ideal investment for long-term growth. Read on….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

StockNews.com

5 Stocks You'll Want in Your Corner if a Recession Hits

Growing fears over a potential recession due to high inflation and the Federal Reserve’s aggressive interest rate hikes should keep the stock market highly volatile in the upcoming months. However, investors could consider buying relatively stable and dividend-paying stocks Procter & Gamble (PG), AbbVie (ABBV), Abbott (ABT), Caterpillar (CAT), and…

StockNews.com

2 Medical Stocks That Are Attractive Buys Right Now

Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right…

StockNews.com

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

Motor1

Audi RS3 Sportback Hulks Out With ABT To Become 500-HP RS3-R

It also gains an aero package and suspension upgrades.

Motorsport

Rast: ABS on GT3 cars "causing" DTM Norisring crashes

Three-time DTM champion Rene Rast says the anti-lock braking systems on GT3 cars are a factor in the high number of crashes seen in the opening race at the Norisring.

Benzinga

Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market capitalization of $187.96 billion.

StockNews.com

This Top-Rated Healthcare Stock Is Trading at a 25% Discount

Medical device company Abbott Laboratories (ABT) reported impressive first-quarter results and affirmed its strong performance guidance for fiscal 2022. Furthermore, the company is well-positioned to benefit from its diversified business. However, amid the heightened market volatility, the stock is trading 25.5% below its 52-week high. So, the current dip in…

Benzinga

FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens

Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at Abbott's Sturgis facility.

StockNews.com

5 Dividend Aristocrats To Buy Now

Last week, the Fed raised its benchmark interest rates three-quarters of a percentage point, marking the most aggressive hike since 1994. And with analysts predicting the economy to slip into a recession, we think dividend aristocrats Abbott (ABT), AbbVie (ABBV), Genuine Parts (GPC), Johnson & Johnson (JNJ), and Sysco (SYY)…

1 … 9 10 11 12

People

Beyoncé

3,326 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

298 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.